Omega 3s are on a clear path forward and will continue to trend in the nutraceutical space, according to Christopher Studte, Director New Health Ingredients, Business Line Health Care at Evonik. Studte highlights how Evonik’s omega 3 offering, AvailOm, is suitable for a wide range of solutions, as well as being three to four times more bioavailable than standard soft gel capsules. He also notes that the company is looking into supplying a vegan option, which will hopefully hit the market later this year.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement















